NCT05900024

Brief Summary

This is a virtual, open-label, single-group study that will last 4 menstrual cycles. All participants will complete a questionnaire at the end of their first period after enrolling (baseline/non-intervention cycle 1), then proceed to take the product daily and complete questionnaires at the end of their next 3 periods (intervention cycles 1, 2, and 3). The study will involve 30 female participants with regular menstrual cycles who experience PMS. Questionnaires will be used to monitor menstrual pain/cramps, energy levels, mood, and hormonal acne experienced before and during the menstrual cycle. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 2, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

4 months

First QC Date

June 2, 2023

Last Update Submit

February 27, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change in symptoms of premenstrual syndrome. [Time Frame: Baseline to Month 4]

    Survey-based assessment of symptoms using the Premenstrual Symptoms Screening Tool (PSST). Responses will be gathered using a 4-point Likert scale.

    4 months

  • Changes in acne. [Time Frame: Baseline to Month 4]

    Survey-based assessment of acne using the Acne Quality of Life (Acne-QOL) scale. Responses will be gathered using a 5-point Likert scale.

    4 months

  • Changes in pain levels, including menstrual cramps. [Time Frame: Baseline to Month 4]

    Survey-based assessment of acne using the Numerical Pain Rating Scale, a 0-10 point rating scale.

    4 months

  • Changes in mood stability. [Time Frame: Baseline to Month 4]

    Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

    4 months

  • Changes in energy levels. [Time Frame: Baseline to Month 4]

    Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

    4 months

Secondary Outcomes (1)

  • Participant enjoyment of the product.

    4 months

Study Arms (1)

Cycle Bites

EXPERIMENTAL

Participants will consume 1 Cycle Bite per day.

Other: Funk It Cycle Bites

Interventions

The intervention product contains: Organic Pumpkin Seed Butter, Prebiotic Agave Inulin, Organic Flax Seed, Organic Oat Flour, Organic Ginger, Quinoa Sprouts, Crispy Red Rice, Organic Cacao Nibs, Sunflower Seed Butter, Organic Reishi Mushroom, Organic Amaranth Seeds, Dates, Organic Button Mushroom, Acai Berry, Amla Fruit, Goji Berry, Pomegranate, Cranberry, Acerola (Cherry Juice), Rosemary Extract, Vitamin E (Mixed Tocopherols), Organic Vanilla Extract, Sea Salt, Cinnamon, Naturally Sourced Potassium Sorbate.

Cycle Bites

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female aged 18-40
  • Have a regular menstrual cycle (every 21-35 days).
  • Suffer from mild to moderate menstrual pain.
  • May experience mood swings and/or hormonal acne related to the menstrual cycle.
  • Otherwise generally healthy.
  • Willing to consume the test product with a ginger flavor.
  • Willing to refrain from taking any other supplements or prescription medications that may target the menstrual cycle or premenstrual syndrome (PMS) symptoms throughout the study period.
  • Willing and able to adhere to the study protocol, including taking supplements at the required times and completing questionnaires via the technology portal.
  • Able to communicate in English.
  • Participants must provide written informed consent (ICF).

You may not qualify if:

  • Any unstable or uncontrolled medical or psychiatric illness.
  • Any uncontrolled chronic disease or condition that would prevent full participation in the study protocol.
  • A history of polycystic ovary syndrome (PCOS), endometriosis, premenstrual dysphoric disorder (PMDD), or undiagnosed vaginal bleeding.
  • Are taking hormonal contraception or exogenous sex hormones (estrogen, testosterone, progesterone), or have taken hormonal contraception or exogenous hormones in the past 6 months.
  • Are taking any prescription medication or supplements that target the menstrual cycle or PMS symptoms.
  • Are pregnant, breastfeeding, trying to become pregnant, or have been pregnant in the past 12 months.
  • Have any known severe allergic reactions, or any allergies of any severity to any of the test product's ingredients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Premenstrual Syndrome

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2023

First Posted

June 12, 2023

Study Start

May 1, 2023

Primary Completion

September 1, 2023

Study Completion

October 1, 2023

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations